NDC 71335-0639 – LAMIVUDINE and ZIDOVUDINE

Lamivudine 150 mg/1; Zidovudine 300 mg/1 · Tablet, Film Coated · Oral

Human Prescription Drug

Product NDC71335-0639

Product details

Brand name
LAMIVUDINE and ZIDOVUDINE
Generic name
LAMIVUDINE and ZIDOVUDINE
Labeler
Bryant Ranch Prepack
Dosage form
Tablet, Film Coated
Route
Oral
Marketing category
ANDA · ANDA079124
Marketed since
September 18, 2015
Listing expires
December 31, 2026
Pharmacologic class
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for LAMIVUDINE and ZIDOVUDINE →

Package NDC codes (3)

Package NDCDescriptionSince
71335-0639-16 TABLET, FILM COATED in 1 BOTTLE (71335-0639-1)Apr 2, 2021
71335-0639-260 TABLET, FILM COATED in 1 BOTTLE (71335-0639-2)Dec 27, 2021
71335-0639-34 TABLET, FILM COATED in 1 BOTTLE (71335-0639-3)Dec 27, 2021

Other LAMIVUDINE and ZIDOVUDINE products